1. Home
  2. MURA vs FAT Comparison

MURA vs FAT Comparison

Compare MURA & FAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MURA
  • FAT
  • Stock Information
  • Founded
  • MURA 2013
  • FAT 2017
  • Country
  • MURA Ireland
  • FAT United States
  • Employees
  • MURA N/A
  • FAT N/A
  • Industry
  • MURA
  • FAT Restaurants
  • Sector
  • MURA
  • FAT Consumer Discretionary
  • Exchange
  • MURA Nasdaq
  • FAT Nasdaq
  • Market Cap
  • MURA 45.8M
  • FAT 45.6M
  • IPO Year
  • MURA N/A
  • FAT 2017
  • Fundamental
  • Price
  • MURA $2.46
  • FAT $2.35
  • Analyst Decision
  • MURA Strong Buy
  • FAT Strong Buy
  • Analyst Count
  • MURA 4
  • FAT 1
  • Target Price
  • MURA $13.00
  • FAT $10.00
  • AVG Volume (30 Days)
  • MURA 106.6K
  • FAT 78.3K
  • Earning Date
  • MURA 08-12-2025
  • FAT 07-30-2025
  • Dividend Yield
  • MURA N/A
  • FAT 11.97%
  • EPS Growth
  • MURA N/A
  • FAT N/A
  • EPS
  • MURA N/A
  • FAT N/A
  • Revenue
  • MURA N/A
  • FAT $582,704,000.00
  • Revenue This Year
  • MURA N/A
  • FAT N/A
  • Revenue Next Year
  • MURA N/A
  • FAT $8.68
  • P/E Ratio
  • MURA N/A
  • FAT N/A
  • Revenue Growth
  • MURA N/A
  • FAT 10.63
  • 52 Week Low
  • MURA $0.95
  • FAT $2.01
  • 52 Week High
  • MURA $4.74
  • FAT $4.10
  • Technical
  • Relative Strength Index (RSI)
  • MURA 44.84
  • FAT 50.54
  • Support Level
  • MURA $2.51
  • FAT $2.42
  • Resistance Level
  • MURA $2.66
  • FAT $2.70
  • Average True Range (ATR)
  • MURA 0.09
  • FAT 0.21
  • MACD
  • MURA -0.02
  • FAT 0.02
  • Stochastic Oscillator
  • MURA 20.08
  • FAT 36.80

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

About FAT FAT Brands Inc.

FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States.

Share on Social Networks: